Brief: Vivimed Labs Says Strides Vivimed JV Receives U.S. FDA Approval For Albendazole Tablets
12/12/2018 07:38
Dec 12 (Reuters) - Vivimed Labs Ltd VVMD.NS :
* STRIDES VIVIMED JV RECEIVES APPROVAL FOR ALBENDAZOLE
TABLETS
Source :(https://bit.ly/2QQaxjC)
Further company coverage: VVMD.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vivimed Labs
See all newsBrief: Vivimed Labs Says Telangana High Court Grants Interim Stay On Proceedings
Brief: Vivimed Labs Ltd Phaninder Nath Resigns As CFO
Brief: Vivimed Labs CFO And CS Receive Notice From CBI
Brief: Vivimed Labs Says Got Notice From Debt Recovery Tribunal Regarding Application Filed By State Bank Of India
Brief: Vivimed Labs Names Ramakanta Tripathy As CFO